PD-L1 binds to PD-1 through a series of signaling pathways, ultimately inhibiting the transcription and translation of genes and cytokines required for T cell activation, exerting a negative regulatory effect on T cell activity, leading to tumor immune escape and promoting tumor growth (40). The gene discussed is CD274; the disease is neoplasm.